PMID: 7506556Oct 1, 1993Paper

A potent, neutralizing human monoclonal antibody against a unique epitope overlapping the CD4-binding site of HIV-1 gp120 that is broadly conserved across North American and African virus isolates

AIDS Research and Human Retroviruses
Abraham PinterS A Tilley


A human monoclonal antibody (HuMAb), 5145A, against HIV-1 gp120 was isolated from an asymptomatic, seropositive hemophiliac. The epitope of this HuMAb was destroyed by reduction of gp120 disulfide bonds, but not by removal of N-linked carbohydrates. This epitope overlaps the CD4-binding site of gp120, because binding of 5145A to gp120 is inhibited by soluble CD4 and by 1125H, a previously described HuMAb directed toward the CD4-binding site. However, the 5145A epitope differs from those of 1125H and other anti-CD4-binding site HuMAbs previously described, as documented by the viral strain specificity of 5145A and its reactivity with a panel of gp120 mutants. Specifically, 5145A reacted with 14 of 15 HIV-1 isolates tested, including 9 isolates from the Central African Republic, 6 of which were not recognized by 1125H. Partial epitope mapping of 5145A, using a series of gp120 mutants, demonstrated its lack of sensitivity to mutations in residues 257 and 427, contrasting with a marked sensitivity to mutations in residues 368 and 370. This pattern of reactivity distinguishes its epitope from that of any HuMAb against the CD4-binding site region described to date. In addition, 5145A exhibited potent and essentially equivalent neutra...Continue Reading


Jun 1, 1992·AIDS Research and Human Retroviruses·S KarwowskaS Zolla-Pazner
Nov 11, 1990·Proceedings of the National Academy of Sciences of the United States of America·C F ScottJ E Robinson
May 1, 1991·The Journal of Clinical Investigation·A J Manheimer-LoryB A Diamond
Dec 1, 1991·AIDS Research and Human Retroviruses·A M PrinceJ W Eichberg
Jul 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·C Y KangH Köhler
Oct 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·A KarpasJ E Epstein
Jan 24, 1985·Nature·L RatnerK Baumeister
Oct 1, 1988·AIDS Research and Human Retroviruses·J P Moore, R F Jarrett
Dec 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A KarpasD Gilgen
Sep 1, 1988·Protein Engineering·M P KienyJ Lecocq
Jan 1, 1980·Methods of Biochemical Analysis·E A Bayer, M Wilchek
Oct 1, 1993·AIDS Research and Human Retroviruses·E MurphyF Barré-Sinoussi

❮ Previous
Next ❯


Jun 14, 2003·Vaccine·Chongbin ZhuChin Ho Chen
Mar 25, 2004·Nature Reviews. Immunology·Susan Zolla-Pazner
Jan 1, 1995·AIDS Research and Human Retroviruses·S DemariaY Bushkin
May 1, 1995·Journal of Medical Primatology·K A Kent
Aug 18, 2005·European Journal of Immunology·Michael TuenCatarina E Hioe
Aug 3, 2004·Expert Review of Vaccines·Indresh K SrivastavaSusan W Barnett
May 19, 2012·Current Opinion in Immunology·Leonidas Stamatatos
Jun 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Yuxian HeAbraham Pinter

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.